Navigation Links
Rheumatologists Underestimate the Patients Ability to Work

Researchers at University of south Florida has found that Rheumatologists substantially overestimate the physical disability of patients with rheumatoid arthritis which may lead to inaccurate evaluations of the patients ability to work and need for lifestyle modifications.

The rheumatologists consistently rated their rheumatoid arthritis patients degree of difficulty in performing activities of daily living, such as walking, dressing and eating, higher than the patients themselves. This was particularly true for patients in advanced stages of the disease.

We flunked, said co-first author John D. Carter, MD, assistant professor of medicine in the USF Division of Rheumatology. The very physicians deemed to be experts in rheumatoid arthritis failed to make the grade when it came to determining their patients functional status.

This discrepancy is important to correct because patients can rely on these assessments for their livelihood or other necessities to perform activities of daily living.

Rheumatologists are frequently asked to complete functional disability reports by employers, disability attorneys, insurance companies and government agencies weighing a persons eligibility for disability payments, employment, or assistive devices such as wheelchairs, walkers, braces and splints.

Using the Stanford Health Assessment Questionnaire-Disability Index (HAQ-DI), rheumatologists evaluated 223 patients during their regularly scheduled visits to the USF Rheumatology Clinics and James A. Haley Veterans Hospital.

The effectiveness of the HAQ-DI, based on patient self-reporting of their disability status, has been validated in clinical studies. The questionnaire covers eight activities of daily living: dressing, arising, eating, hygiene, walking, reach, grip and outside activity.

Both physician and patient completed the HAQ-DI independently immediately following the visit and the ir respective scores were not shared.

The rheumatologists overestimated the degree of functional disability in 154, or 69 percent, of the 223 the patients. However, they were significantly more accurate at determining the degree of physical limitations in patients with less severe disease.

The reasons for the overestimation are unclear, but may include empathy and suggest that even patients with advanced rheumatoid arthritis adapt their activities to the progression of the chronic disease, Dr. Carter said. We tend to associate visible joint deformities with incapacitated function, but patients may actually be more capable than we think.

Rheumatologists typically determine functional disability based on the patients examination and medical history, but these impressions during routine care are inadequate, Dr. Carter said.

The study points to the need for a formal, standardized evaluation, such as the HAQ-DI. It needs to be reimbursable and include input from physical and occupational therapists who could add valuable insight to the process of evaluating disability, he added.

Rheumatoid arthritis affects about 2.1 million Americans, or 1 percent of the population. Over the last decade new drugs have revolutionized the treatment of this debilitating inflammatory disease, but nearly all patients with rheumatoid arthritis eventually develop some degree of work or daily lifestyle disability, often severe.


'"/>




Related medicine news :

1. Breast Cancer in Men Often Underestimated and Under-treated
2. Importance of Retroviral Drugs Underestimated
3. Number of Heat-Related Deaths is Underestimated by Over 50%
4. Biopsy may Underestimate Prostate Cancer in Obese and Overweight Men
5. One in Three Heart Attack Patients Have No Chest Pains
6. Amphetamines Help Recovery of Stroke Patients
7. Painkillers Do Not Shorten Dying Patients Lives
8. Patients With Filariasis More Prone To HIV Infection
9. Glivec - New Hope For CMC Patients
10. Patients often assume wrongly that they are allergic to penicillin
11. New FDA Approved Drug NATRECOR For Heart Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... April 29, 2016 , ... For those who skip ... meal to miss. That was among the many new lifestyle diet tips offered by ... Sharon Kleyne Hour® Power of Water® radio show. Bonny and Lawrence noted that because ...
(Date:4/29/2016)... ... April 29, 2016 , ... Innovations with Ed Begley ... upcoming episode, airing third quarter 2016 via Discovery Channel. Dates and show times ... Dairy Products, located in Greenwood, Wisconsin applies product research and development and continuous ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... focused entirely on patients with cancer, today announced that Lynne Malestic, RN, of ... 2016 CURE® Extraordinary Healer® for Oncology Nursing , which honors nurses who ...
(Date:4/29/2016)... ... April 29, 2016 , ... Nike Softball Camp at ... from July 24th – 27th for girls aged 10-18. All facets of the game ... the beautiful Clark V. Whited Complex, one of the finest softball facilities in the ...
(Date:4/29/2016)... , ... April 29, 2016 , ... International Dehydrated Foods, ... on May 3 and 4 at the Doubletree by Hilton Hotel in Oak Brook, ... to marketing and applications technologies for protein ingredients. , At the seminar, IDF™ will ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 Oramed ... a clinical-stage pharmaceutical company focused on the development of oral ... in the upcoming PIONEERS 2016 conference, presented by Joseph ... 2016 in New York . Nadav ... at the conference. Presentation Details:   ...
(Date:4/28/2016)... FREMONT, Calif. , April 28, 2016 ... Enterprise Validation Lifecycle Management Solutions (VLMS) today ... products and services for sufferers of chronic ... management System to manage their corporate validation ... been seeking a software solution to manage ...
(Date:4/28/2016)... , April 28, 2016 ... Review, H1 2016" is a report that provides ... helps strengthen R&D pipelines by identifying new targets ... Company Profiles discussed in this H1 ... Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., ...
Breaking Medicine Technology: